Intratympanic steroid therapy in moderate sudden hearing loss: A randomized, triple‐blind, placebo‐controlled trial

Abstract

The mean PTA recorded after the first-line approach (T1) demonstrated a significant therapeutic action of the short-duration intratympanic steroid therapy on moderate ISSNHL, with a flat audiogram shape, compared to the natural course of the disease and the placebo effect at that time point.